Skip to main content
. 2020 Mar 6;99(10):e19359. doi: 10.1097/MD.0000000000019359

Table 2.

Agreement of infliximab and anti-infliximab serum concentrations with selected clinical, endoscopic, and laboratory variables.

3.2.